Abstract
Objective
To observe the clinical curative effect of Chinese medicine Bushen Huoxue Granule(补肾活血颗粒, BHG) on Parkinson’s disease (PD) patients with depressive state.
Methods
Sixty-two PD patients with depressive state were randomly assigned to two groups by using a random number table, 31 in each group. Madopar was given to all as the conventional treatment. The fluoxetine hydrochloride dispersible tablet was given to the patients in the control group and BHG was given to those in the treatment group. The therapeutic course for all was 12 weeks. Before and after treatment, Hamilton depression rating scale (HAMD) was applied to judge the curative effect, and the changes of cerebral neurotransmitters levels in the brain of patients were detected by encephalofluctuograph technique.
Results
The scores of HAMD in the two groups were decreased markedly after 12-week treatment. It was lower in the treatment group than that in the control group with significant difference (P<0.01). The contents of norepinephrine (NE) and 5-serotonin (5-HT) in the PD patients were obviously lower than normal value. There was no significant difference between the two groups before treatment (P>0.05). The contents of NE and 5-HT were all increased in the two groups after treatment (P<0.05), with significant differences between the two groups (P<0.01).
Conclusion
BHG could increase the contents of NE and 5-HT in PD patients’ brain to improve the depressive state of PD patients.
Similar content being viewed by others
References
Liu CY, Wang SJ, Fuh JI, Lin CH, Yang YY, Lin HC. The correlation of depression with functional activity in Parkinson disease. J Neurol 1997;224:493–498.
Gibb UR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:745–752.
Nation DA, Katzen H L, Papapetropoulos S. Subthreshold depression in Parkinson’s disease. Int J Geriatr Psychiatry 2011;24:937 943.
Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, et al. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: a multicenter, randomized, double-blind and placebo-controlled trial. J Chin Integr Med 2010;8:231–237.
Li JY, Yang MH, Zhao GY, Wang ZF. Application EEG ultra slow fluctuation figure changes in neurotransmitter in the brain of patients with Parkinson’s research. Chin J Difficult Complic Cases (Chin) 2009;1:3–5.
Yang MH, Wang HM, Liu Y. Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson’s disease. Chin J Integr Med 2010;17:43–47.
Ai HX, Li L, Xu DM, Wang W, Zhang PC, Zhang L, et al. Morroniside of focal cerebral ischemia and reperfusion in rat cortex total antioxidant capacity. Chin J Rehabil Theory Pract (Chin) 2009;15:833–834.
Zheng HY, Zeng SL, Li T. Experimental study of Parkinson’s disease transplanted neuronal survival Salvia miltiorrhiza Injection. Jiangsu Pharmaceut Clin Res (Chin) 2004;12:1–3.
Li X, Zuo DY, Chen JJ, Wu LY. Polygonum multiflorum extract on monoamine neurotransmitters in a mouse model of behavior and striatum of paraquat and maneb content. J Shenyang Pharm Univ (Chin) 2006;23:797–801
Long R, Du JR, Chen SJ. Angelica lactone free radical scavenging and antioxidant activity. West China J Pharmaceut Sci (Chin) 2010;25:420–422.
Si QJ, Wang XG. Centipede of atherosclerotic vascular endothelial cell function in rabbits. Pharmacol Clin Chin Mater Med (Chin) 2002;18:28–30.
Huang ZY, Li WZ, Wu XX. Parkinson’s disease patients’ quality of life status and related influencing factors. Hainan Med (Chin) 2011;22:14–16.
Cheng Y, Liu C, Mao C, Qian J, Liu K, Ke G. Social support plays a role in depression in Parkinson’s disease: acrosssection study in a Chinese cohort. Parkinsonism Relat Disord (Chin) 2008;14:43–45.
Pålhagen SE, Ekberg S, Wålinder J, Granérus AK, Granerus G. HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment. J Neuro 2009;256:1510–1518.
Zhao HQ, Duan YY, Liu YG. The role of 5-hydroxytryptamine in suicidal behavior. Shandong Psychiatry (Chin) 2004;17:54–56.
David JB, Paola P. Imaging in Parkinson’s disease: the role of monoamines in behavior. Biol Psychiat 2006;59:908–918.
Quera-Salva MA, Lemoine P, Guilleminault C. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Human Psychopharmacol 2010;25:222–229.
Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson’s disease:loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314–1322.
Mei L, ed. ET-brain function testing new technology. Beijing: National Defense Industry Press; 1995:1–98.
Dou YQ, Yang MH, Liu Y, Wei ZM. Integrative Medicine Parkinson Disease Control Observation. Chin J Clin Rehabil (Chin) 2006;10:6–8.
Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, et al. Kidney and activating blood particles affect motor function in patients with Parkinson: multi-center, randomized, double-blind, placebo-controlled study. Chin J Integr Med 2010;18:31–37.
Yang MH, Wang HM, Liu Y. Kidney and activating blood drinking rotation behavior and brain M5 receptor mRNA expression of Parkinson’s disease in rats. Chin J Diffic Complic Cases (Chin) 2008;7:577–579.
Liu MH, Wang HM, Liu Y. Kidney and activating blood to drink a the PD rat tyrosine hydroxylase (TH) and the orphan nuclear receptor (the silencing effects of Nurr1) mRNA impact. Chin J Integr Tradit West Med Intens Critic Care (Chin) 2009;16:72–74.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (No. 30672762)
Rights and permissions
About this article
Cite this article
Wang, Hm., Yang, Mh., Liu, Y. et al. Effectiveness of Bushen Huoxue Granule (补肾活血颗粒) on 5-serotonin and norepinephrine in the brain of Parkinson’s disease patients with depressive state. Chin. J. Integr. Med. 20, 944–948 (2014). https://doi.org/10.1007/s11655-014-2029-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-014-2029-6